APA aipamena

Le Guyader, G., Vieillard, V., Andrieux, K., Rollo, M., Thirion, O., Wolkenstein, P., & Paul, M. (2020). Long-term stability of 0.1% rapamycin hydrophilic gel in the treatment of facial angiofibromas. Eur J Hosp Pharm.

Chicago Style aipamena

Le Guyader, Guillaume, Victoire Vieillard, Karine Andrieux, Mylène Rollo, Olivier Thirion, Pierre Wolkenstein, and Muriel Paul. "Long-term Stability of 0.1% Rapamycin Hydrophilic Gel in the Treatment of Facial Angiofibromas." Eur J Hosp Pharm 2020.

MLA aipamena

Le Guyader, Guillaume, et al. "Long-term Stability of 0.1% Rapamycin Hydrophilic Gel in the Treatment of Facial Angiofibromas." Eur J Hosp Pharm 2020.